These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients. Budde K; Fritsche L; Waiser J; Glander P; Slowinski T; Neumayer HH; Eur J Med Res; 2005 Apr; 10(4):169-74. PubMed ID: 15946913 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C; Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038 [TBL] [Abstract][Full Text] [Related]
4. Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients. Budde K; Lehne G; Winkler M; Renders L; Lison A; Fritsche L; Soulillou JP; Fauchald P; Neumayer HH; Dantal J; J Clin Pharmacol; 2005 Jul; 45(7):781-91. PubMed ID: 15951468 [TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Levy G; Schmidli H; Punch J; Tuttle-Newhall E; Mayer D; Neuhaus P; Samuel D; Nashan B; Klempnauer J; Langnas A; Calmus Y; Rogiers X; Abecassis M; Freeman R; Sloof M; Roberts J; Fischer L Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression. Iaria G; Pisani F; Iorio B; Lucchesi C; De Luca L; Ielpo B; D'Andria D; Tariciotti L; Tisone G Transplant Proc; 2006 May; 38(4):1018-9. PubMed ID: 16757249 [TBL] [Abstract][Full Text] [Related]
17. Conversion to everolimus in maintenance patients--current clinical strategies. Pohanka E Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii24-9. PubMed ID: 16815853 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients. Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR; J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227 [TBL] [Abstract][Full Text] [Related]
19. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine. Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975 [TBL] [Abstract][Full Text] [Related]
20. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Montagnino G; Sandrini S; Iorio B; Schena FP; Carmellini M; Rigotti P; Cossu M; Altieri P; Salvadori M; Stefoni S; Corbetta G; Ponticelli C Nephrol Dial Transplant; 2008 Feb; 23(2):707-14. PubMed ID: 17890244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]